The main threat from a beginning thrombus is that it tends to grow, and hen
ce become occlusive and/or embolise. Although the progressive nature of thr
ombi has been recognised since a long time, the mechanisms behind thrombus
growth remain only partially resolved. In order to investigate in what ways
thrombi can themselves become foci of further thrombin - and hence fibrin
-formation, we studied the effect of fibrin clots on thrombin generation in
platelet poor - and platelet rich plasma (PPP and PRP). The thrombin alway
s adsorbed on a natural fibrin clot is not inactivated by plasmatic antithr
ombins and could be shown to retain its ability to enhance further thrombin
formation by activation of clotting factors V and VIII as well as of blood
platelets. To our surprise, fibrin clots without any active thrombin adsor
bed because they were obtained by a snake-venom enzyme or because thrombin
had been inhibited retained their capacity to activate blood platelets and
make them procoagulant. The activation could be shown to be due to a rearra
ngement of cell-membrane phospholipids, by which the procoagulant species (
phosphatidyl serine and phosphatidyl ethanolamine) became available at the
outer cell surface. The platelet membrane receptor involved could be recogn
ised as glycoprotein Ib, interacting with fibrin through the plasma protein
von Willebrand factor (vWf). In fact it appeared that vWf is indispensable
for the generation of thrombin in PRP with or without added clot. This ass
igns a new and hitherto to unknown role to vWf: Our results also show that
fibrin is far from being the inert end-product of coagulation but is a pote
nt activator of blood platelets and by this action may foster thrombin gene
ration and hence further fibrin production. We surmise this mechanism to be
instrumental in the progression of thrombotic processes.